References
- Wang B, Shelat VG, Chow JJL, et al. Prehabilitation Program Improves Outcomes of Patients Undergoing Elective Liver Resection. J Surg Res. 2020;251:119–125. doi:https://doi.org/10.1016/j.jss.2020.01.009.
- Gui CH, Baey S, D’Cruz RT, Shelat VG . Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma—A meta-analysis. Eur J Surg Oncol. 2020;46(5):763–771. doi:https://doi.org/10.1016/j.ejso.2020.01.004.
- Xuan D, Wen W, Xu D, Jin T. Survival comparison between radiofrequency ablation and surgical resection for patients with small hepatocellular carcinoma: A systematic review and meta-analysis. Medicine (Baltimore). 2021;100(7):e24585. doi:https://doi.org/10.1097/MD.0000000000024585.
- Qu C, Li X-Q, Xia F, Xia F, Feng K, Ma K. The short-term efficacy of novel no-touch combined directional perfusion radiofrequency ablation in the treatment of small hepatocellular carcinoma with cirrhosis. J Invest Surg. 2021:1–8.: doi:https://doi.org/10.1080/08941939.2021.1931575.
- Pandya GJ, Shelat VG. Radiofrequency ablation of pancreatic ductal adenocarcinoma: the past, the present and the future. World J Gastrointest Oncol. 2015;7(2):6–11. doi:https://doi.org/10.4251/wjgo.v7.i2.6.
- Hocquelet A, Aubé C, Rode A, et al. Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC. J Hepatol. 2017;66(1):67–74. doi:https://doi.org/10.1016/j.jhep.2016.07.010.
- Hirooka M, Ochi H, Hiraoka A, et al. Multipolar versus monopolar radiofrequency ablation for hepatocellular carcinoma in the caudate lobe: Results of a propensity score analysis. Hepatol Res. 2017;47(7):658–667. doi:https://doi.org/10.1111/hepr.12791.
- Shin SW, Ahn KS, Kim SW, Kim TS, Kim YH, Kang KJ. Liver resection versus local ablation therapies for hepatocellular carcinoma within the Milan criteria: A systematic review and meta-analysis. Ann Surg. 2021;273(4):656–666. doi:https://doi.org/10.1097/SLA.0000000000004350.
- Stigliano R, Marelli L, Yu D, Davies N, Patch D, Burroughs AK. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev. 2007;33(5):437–447. doi:https://doi.org/10.1016/j.ctrv.2007.04.001.
- Poon RT, Ng KK, Lam CM, et al. Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg. 2004;239(4):441–449. doi:https://doi.org/10.1097/01.sla.0000118565.21298.0a.